Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for identifying modified tumor necrosis factor-alpha converting enzyme inhibitors

Methods for identifying modified tumor necrosis factor-alpha converting enzyme inhibitors

US Patent 7529628 · Granted May 5, 2009

Estimated economic value: $132,890,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Factor XIIa inhibitors2021
Crystals of anti-human PD-1 monoclonal antibodies2021
Factor XIIa inhibitors2020
Engineered anti-IL-23p19 antibodies2017
Engineered anti-IL-23p19 antibodies2017
Engineered anti-IL-23p19 antibodies2017
Crystalline anti-human IL-23p19 antibodies2017
C.difficile toxin B CROP domain peptides, antibodies and complexes thereof2015
C.difficile toxin B CROP domain peptides, antibodies and complexes thereof2015
Cyclic amide BACE-1 inhibitors having a benzamide substituent2015
Substituted quinoxalines as inhibitors of fatty acid binding protein2014
Heterocyclic aspartyl protease inhibitors2014